AIDS 2024
Long-Acting Injectable Cabenuva Shows Strong Results in Adolescents
Data from the IMPAACT 2017/MOCHA study support the use of long-acting Cabenuva among virologically suppressed ...
JULY 25, 2024
Twice-Yearly Lenacapavir 100% Effective in Preventing HIV Among Cisgender Women
An interim analysis of PURPOSE 1 found twice-yearly lenacapavir was superior to once-daily oral FTC/TDF in ...
JULY 24, 2024
High Virologic Suppression Seen With DTG/3TC Among Patients With Reactive HBV Core Antibody
Dovato demonstrates high rates of virologic suppression among people living with HIV and who have reactive anti-HBc ...
JULY 23, 2024
HIV Cure 2.0: The Next Berlin Patient
The latest person to be cured of HIV has an important distinction from the previous six people—the stem cell ...
JULY 22, 2024
Load more